RBQM And ML: Perfect Partners For More Efficient Clinical Trials
Artificial intelligence (AI) and risk-based quality management (RBQM) are growing trends in pharma – and the two go together like strawberries and cream. For decades,
Twin Peaks: 10 Years Of CluePoints And Risk-Based Monitoring
It’s been ten years since CluePoints set out on a journey to let clinical trial data speak for itself – and what a journey it
The Inaugural ACDM AI & ML Conference Promises To Move The Dial
CluePoints is excited to participate in a brand-new annual conference designed to help the research sector level up its artificial intelligence (AI) and machine learning
Natural Language Processing Improves Risk Signal Documentation In Clinical Trials
Authors: Sylviane de Viron, Data and Knowledge Manager Nicolas Huet, Machine Learning Manager Central monitoring helps sponsors proactively identify quality issues in clinical trials. To
The Best Of Both: The Key Reasons To Outsource RBQM Tech But Keep Data Control
You can outsource the work, but you can’t outsource the responsibility – so should you outsource Risk-Based Quality Management (RBQM)? It’s a question pharma companies
10 Reasons Why CROs Leverage CluePoints For RBQM
Written by Andrea McSweeney, Vice President of Customer Success – Channel, CluePoints Contract research organizations (CROs) are uniquely positioned to partner with sponsors on risk
CluePoints To Share Case Study On Technology ROI At The SCDM 2022 EMEA Leadership Forum & Conference
Decentralized clinical trials (DCTs) have become a buzzphrase in recent years, with commentators lining up to extol the benefits of this new way of working.
Join Us At DIA 2022 As We Demystify The De-Risking Of DCTs
The world of decentralized clinical trials (DCTs) and risk-based quality management is evolving rapidly – but CluePoints and our partners are here to help you
10 Ways The Pandemic Changed CluePoints
AUTHOR: PATRICK HUGHES, CO-FOUNDER & CHIEF COMMERCIAL OFFICER, CLUEPOINTS As CluePoints celebrates ten years as the leading provider of Risk-Based Study Execution (RBx) and Risk-Based
Does Central Monitoring Lead To Higher Quality? An Analysis Of KRI Outcomes
AUTHOR: SYLVIANE DE VIRON, MANAGER, DATA & KNOWLEDGE, CLUEPOINTS AND WILLIAM STEIJN, RESEARCH DATA ANALYST, CLUEPOINTS Central Monitoring is a key component of Risk-Based Quality
